Erich Rajkovic — Head of Research Operations and Intellectual Property at Affimed N.V.

Dr. Erich Rajkovic has been Head of Research Operations and Intellectual Property at Affimed N.V. since 2016. Dr. Rajkovic served as the Head of Business Development and Alliance Management at Affimed N.V. from 2013 to 2016. He joined Affimed Therapeutics in 2007 as Scientist in antibody discovery and antibody engineering. In 2010, he joined Affimed Therapeutics Business Development team and was promoted to Director of Business Development in 2011. Since 2013, he has been responsible for Business Development & Alliance Management. He played a key role in the negotiations with Amphivena and Janssen and with The Leukemia & Lymphoma Society. In addition, Dr. Rajkovic is leading the negotiations of the cGMP manufacturing and clinical trial agreements. Prior to Affimed, Dr. Rajkovic worked for Kwizda Pharma (Austria). He studied pharmacy and received his Ph.D. in protein chemistry and biophysics from the University of Graz (Austria) in 2006.